Skip Navigation
Text Size: A  A  A
Genetic and Rare Diseases Information Center (GARD)



Carnitine-acylcarnitine translocase deficiency
ORDR lists rare diseases for information purposes only and does not guarantee that a condition is rare. Read more
The links on this page may take you to sites outside of the NIH. (See Disclaimer for details.)


Carnitine-acylcarnitine translocase deficiency is a condition that prevents the body from converting certain fats called long-chain fatty acids into energy, particularly during periods without food (fasting). Carnitine, a natural substance acquired mostly through the diet, is used by cells to process fats and produce energy. People with this disorder have a faulty transporter that disrupts carnitine's role in processing long-chain fatty acids.[1] Carnitine-acylcarnitine translocase deficiency is a type of fatty acid oxidation disorder. There are two forms of carnitine-acylcarnitine translocase deficiency. The most common type happens in newborns. A milder, less common type happens in older infants and children.[2]


References
  1. Carnitine-acylcarnitine translocase deficiency. Genetics Home Reference. August 2006 Available at: http://ghr.nlm.nih.gov/condition=carnitineacylcarnitinetranslocasedeficiency. Accessed April 4, 2008.
  2. Carnitine-acylcarnitine translocase deficiency. Screening, Technology and Research in Genetics. October 5, 2007 Available at: http://www.newbornscreening.info/Parents/fattyaciddisorders/CAT.html. Accessed April 4, 2008.
click to take you to contact us form

Questions & Answers (Found 1 Question)
A list of questions from the public on rare and/or genetic diseases that have been answered by the Genetic and Rare Disease Information Center. Click on each question to find the answer.
For more information about Carnitine-acylcarnitine translocase deficiency click on the boxes below:
More Detailed Information Organizations Services Scientific Conferences Clinical Trials & Research